What is the cumulative prevalence of colon (large intestine) cancer in a population of 100,000 individuals with 300 new cases and 75 existing cases?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cumulative Prevalence Calculation for Colon Cancer

The cumulative prevalence is 0.375% (Option A), calculated by adding new cases (300) plus existing cases (75) divided by the total population (100,000), which equals 375 per 100,000 or 0.375%.

Understanding the Calculation

Cumulative prevalence represents the total burden of disease in a population at a specific point in time, including both new and pre-existing cases.

  • Cumulative prevalence = (New cases + Existing cases) / Total population × 100
  • In this scenario: (300 + 75) / 100,000 × 100 = 0.375%

Why This Matters Clinically

  • This prevalence rate of 0.375% (375 per 100,000) aligns with contemporary colorectal cancer burden data, where age-standardized incidence rates range from approximately 30-45 per 100,000 in most populations 1
  • The cumulative prevalence accounts for both incident cases (new diagnoses) and prevalent cases (existing survivors), which is critical for healthcare resource planning 2
  • Global estimates indicate colorectal cancer represents approximately 10% of all tumor types worldwide, with cumulative risk of onset between 0-74 years being approximately 2.27% 3, 2

Common Pitfalls to Avoid

  • Do not confuse prevalence with incidence: Incidence only counts new cases, while prevalence includes all existing cases in the population
  • Do not express as "per 1000": Options C and D are incorrect because 0.375 per 1000 would equal 0.0375%, which is 10-fold lower than the correct answer
  • Do not use only new cases: The 300 new cases alone would give incidence (0.3%), not cumulative prevalence

Clinical Context

  • Colorectal cancer is the third most common cancer worldwide and second leading cause of cancer death 1, 3
  • Understanding prevalence versus incidence is essential for distinguishing screening needs (which target incident disease) from treatment burden (which reflects prevalent disease) 1
  • The mortality-to-incidence ratio globally stands at approximately 0.48, indicating that roughly half of diagnosed patients will die from the disease, emphasizing the importance of early detection 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Concise update on colorectal cancer epidemiology.

Annals of translational medicine, 2019

Guideline

Colorectal Cancer Epidemiology and Characteristics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.